Europska Unija - norveški - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - guanfacin hydroklorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv må brukes som en del av en omfattende adhd behandling program, vanligvis inkludert psykologiske, pedagogiske og sosiale tiltak.

Norveška - norveški - Statens legemiddelverk

menarini international o.l. s.a. - nebivololhydroklorid - tablett - 5 mg

Norveška - norveški - Statens legemiddelverk

menarini international o.l. sa - nebivololhydroklorid / hydroklortiazid - tablett, filmdrasjert - 5 mg / 12.5 mg

Norveška - norveški - Statens legemiddelverk

macure pharma aps - metoprololtartrat - injeksjonsvæske, oppløsning - 1 mg/ ml

Norveška - norveški - Statens legemiddelverk

takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 30 mg

Norveška - norveški - Statens legemiddelverk

takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 20 mg

Norveška - norveški - Statens legemiddelverk

takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 40 mg

Norveška - norveški - Statens legemiddelverk

takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 50 mg

Norveška - norveški - Statens legemiddelverk

takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 60 mg

Norveška - norveški - Statens legemiddelverk

takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 70 mg